CDRE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cadre Holdings Inc (CDRE) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock has recently experienced a significant decline in price (-9.26% regular market change), and its financial performance in Q4 2025 showed declines across key metrics, including revenue, net income, and EPS. While analysts have raised price targets and maintained a Buy rating due to the TYR Tactical acquisition, the stock's technical indicators suggest bearish momentum. Additionally, insider selling has significantly increased, and there are no recent congress trading data or proprietary trading signals to support a buy decision. Considering the investor's profile and the current data, holding off on purchasing this stock is recommended until further positive catalysts emerge or the stock stabilizes.
The technical indicators for CDRE show bearish momentum. The MACD histogram is -1.188, below 0, and negatively expanding, indicating downward pressure. The RSI is at 11.175, which signals the stock is oversold. Moving averages are converging, and the stock is trading near its S2 support level of 30.335, suggesting further downside risk. Overall, the technical setup is weak.
Analysts have raised price targets to $50-$53 and maintained Buy ratings, citing the acquisition of TYR Tactical, which is expected to be accretive to earnings and adjusted EBITDA margins. The company also reported a nearly 50% increase in backlog, indicating potential future revenue growth.
Q4 2025 financial performance missed expectations, with revenue down 4.98% YoY, net income down 9.58% YoY, and EPS down 28.12% YoY. Insider selling has increased by 15531.04% over the last month. The stock has experienced a significant price decline (-9.26% regular market change), and there is an ongoing investigation into potential compliance with federal securities laws.
In Q4 2025, Cadre Holdings reported revenue of $167.2 million, down 4.98% YoY. Net income dropped to $11.74 million, down 9.58% YoY, and EPS fell to $0.23, down 28.12% YoY. Gross margin decreased slightly to 43.43%, down 0.98% YoY. These results indicate declining financial performance.
Analysts from Lake Street and Roth Capital have raised price targets to $50-$53 and maintained Buy ratings, citing the accretive impact of the TYR Tactical acquisition on revenue and margins. However, the stock's recent performance and financial results may limit immediate upside potential.
